[Summary] 致力于抗肿瘤药物新剂型及相关产品的开发
上海谊众生物技术有限公司成立于2009年,注册资金6875万元。公司致力于抗肿瘤药物新剂型及相关产品的开发,主研产品“注射用紫杉醇胶束”是抗肿瘤治疗用大品种——紫杉醇的一种新剂型。该产品已获多项国家专利,目前正在进行三期临床研究及产业化项目。
注射用紫杉醇聚合物胶束是由上海谊众生物技术有限公司及时追踪国际上刚上市的抗肿瘤治疗用大品种——紫杉醇胶束进行仿创的一种紫杉醇新剂型。该制剂避免了传统紫杉醇注射液中聚氧乙烯蓖麻油和无水乙醇混合溶剂的使用,成功克服了传统紫杉醇注射液过敏性强,使用前需作抗过敏预处理的缺点,同时可大幅降低常规紫杉醇注射液的血液毒性,提高药物使用的安全性及靶向性。
What does 上海谊众药业股份有限公司 require? Who is 上海谊众药业 hiring? 上海谊众药业 recruitment: 技工类占比最多占41.7%,其次是销售类占33.3%. What education can get in at 上海谊众药业? 大专占比最多占58.3%,其次是本科占33.3%. High education required at 上海谊众药业? 硕士占8.3%. Work experience required at 上海谊众药业? 1-3年占比最多占75%,其次是不限占25%. Where are the job locations at 上海谊众药业? 上海占比最多占66.7%,其次是石家庄占16.7%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows